MYX 3.67% $3.95 mayne pharma group limited

Shorts should start to cover here. Revenues stable with new...

  1. 719 Posts.
    lightbulb Created with Sketch. 38

    Shorts should start to cover here.

    Revenues stable with new product launches coming and the write downs have set a low hurdle for growth.

    Should be a better year ahead backed by hopefully a few product approvals in the near term to get this moving in the right direction.

    .

 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.